125 related articles for article (PubMed ID: 37962044)
1. Combining Network Pharmacology, Molecular Docking and Preliminary Experiments to Explore the Mechanism of Action of FZKA Formula on Non-small Cell Lung Cancer.
Liu Z; Zhang J; Liu J; Guo L; Chen G; Fang Y; Yang Y
Protein Pept Lett; 2023; 30(12):1038-1047. PubMed ID: 37962044
[TBL] [Abstract][Full Text] [Related]
2. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective Mechanism and Active Compounds of
Sun X; Zhu Y; Li F; Li M; Wan G
Comput Math Methods Med; 2022; 2022():4338260. PubMed ID: 36213575
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huang-Qi-Gui-Zhi-Wu-Wu decoction against deep vein thrombosis.
Fan W; Lan S; Yang Y; Liang J
J Orthop Surg Res; 2023 Jun; 18(1):475. PubMed ID: 37391801
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
[TBL] [Abstract][Full Text] [Related]
11. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of Lung Cancer.
Zhang YC; Gao WC; Chen WJ; Pang DX; Mo DY; Yang M
Curr Pharm Des; 2023; 29(14):1121-1134. PubMed ID: 37138492
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology.
Qiang R; Zhang Y; Wang Y
Dis Markers; 2022; 2022():8925637. PubMed ID: 36246566
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Mechanism of
Zhu J; Han M; Yang Y; Feng R; Hu Y; Wang Y
Comb Chem High Throughput Screen; 2024; 27(1):157-167. PubMed ID: 37366364
[TBL] [Abstract][Full Text] [Related]
15. To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology.
Chen X; Wang Y; Ma Y; Wang R; Zhao D
Medicine (Baltimore); 2021 Dec; 100(49):e27752. PubMed ID: 34889224
[TBL] [Abstract][Full Text] [Related]
16. Integration of UPLC-QE-MS/MS and network pharmacology to investigate the active components and action mechanisms of tea cake extract for treating cough.
Lin C; Liu Z; Chen J; Wang X; Zhang R; Wu L; Li L
Biomed Chromatogr; 2022 Oct; 36(10):e5442. PubMed ID: 35781817
[TBL] [Abstract][Full Text] [Related]
17. Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking.
Li Y; Liu B; Liu L; Xu Q; Shen Q; Li W; Zhao J
Medicine (Baltimore); 2022 Aug; 101(32):e29654. PubMed ID: 35960089
[TBL] [Abstract][Full Text] [Related]
18. Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.
Cao S; Hou G; Meng Y; Chen Y; Xie L; Shi B
Dis Markers; 2022; 2022():2141882. PubMed ID: 36157206
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of the mechanism of Zhenbao pills for the treatment of spinal cord injury by network pharmacology and molecular docking: A review.
Xu M; Zhang W; Xu S; Niu X; Wang L; Wang X; Hao H
Medicine (Baltimore); 2024 Feb; 103(7):e36970. PubMed ID: 38363936
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury.
Wang Y; Chen X; Wang Y; Zhong H; Liu L; Ye Y
Medicine (Baltimore); 2023 Dec; 102(48):e36349. PubMed ID: 38050247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
